.After bring up $213 million in 2023-- one of the year's most extensive private biotech shots-- Tome...
.Accept to today's Chutes & Ladders, our roundup of significant management hirings, shootings and...
.Venture capital backing right into biopharma rose to $9.2 billion across 215 deals in the 2nd one-f...
.Bicara Therapies and Zenas Biopharma have provided new incentive to the IPO market along with filin...
.Genentech will shut its own cancer immunology research team, as well as device head as well as well...
.Kezar Lifestyle Sciences is losing its dim stage 1 solid tumor medicine as the biotech goes all-in ...
.Despite izokibep sustaining its newly found winning streak in the facility, Acelyrin is no more pay...
.Rivus Pharmaceuticals has plumped up the customers of its fat-busting, muscle-sparing medication pr...
.Ovid Therapy presently uncovered final month that it was actually trimming its headcount as the bus...
.Eli Lilly has opened up a $700 million R&D center in the Boston ma Port, boosting its RNA as wel...